栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/12/30 | 1,697 | 1,721 | 1,696 | 1,709 | -6 | -0.3% | 208,000 |
| 2022/12/29 | 1,715 | 1,720 | 1,699 | 1,715 | +5 | +0.3% | 191,100 |
| 2022/12/28 | 1,715 | 1,715 | 1,696 | 1,710 | -24 | -1.4% | 167,200 |
| 2022/12/27 | 1,718 | 1,743 | 1,713 | 1,734 | +31 | +1.8% | 183,800 |
| 2022/12/26 | 1,710 | 1,716 | 1,691 | 1,703 | ±0 | ±0% | 144,500 |
| 2022/12/23 | 1,720 | 1,720 | 1,696 | 1,703 | -32 | -1.8% | 134,300 |
| 2022/12/22 | 1,737 | 1,745 | 1,724 | 1,735 | -18 | -1% | 127,100 |
| 2022/12/21 | 1,771 | 1,783 | 1,730 | 1,753 | -32 | -1.8% | 172,700 |
| 2022/12/20 | 1,853 | 1,858 | 1,771 | 1,785 | -60 | -3.3% | 321,200 |
| 2022/12/19 | 1,819 | 1,846 | 1,819 | 1,845 | +7 | +0.4% | 123,000 |
| 2022/12/16 | 1,838 | 1,855 | 1,831 | 1,838 | -14 | -0.8% | 133,500 |
| 2022/12/15 | 1,863 | 1,864 | 1,851 | 1,852 | -12 | -0.6% | 28,300 |
| 2022/12/14 | 1,852 | 1,870 | 1,850 | 1,864 | +24 | +1.3% | 105,800 |
| 2022/12/13 | 1,850 | 1,862 | 1,837 | 1,840 | -14 | -0.8% | 67,000 |
| 2022/12/12 | 1,853 | 1,860 | 1,839 | 1,854 | +2 | +0.1% | 69,700 |
| 2022/12/09 | 1,837 | 1,854 | 1,824 | 1,852 | +29 | +1.6% | 76,500 |
| 2022/12/08 | 1,819 | 1,833 | 1,808 | 1,823 | +6 | +0.3% | 84,700 |
| 2022/12/07 | 1,787 | 1,826 | 1,782 | 1,817 | +33 | +1.8% | 78,200 |
| 2022/12/06 | 1,790 | 1,796 | 1,775 | 1,784 | -12 | -0.7% | 75,500 |
| 2022/12/05 | 1,821 | 1,821 | 1,788 | 1,796 | -30 | -1.6% | 85,200 |
| 2022/12/02 | 1,865 | 1,866 | 1,825 | 1,826 | -51 | -2.7% | 104,800 |
| 2022/12/01 | 1,906 | 1,906 | 1,866 | 1,877 | -26 | -1.4% | 72,200 |
| 2022/11/30 | 1,917 | 1,917 | 1,889 | 1,903 | -30 | -1.6% | 119,700 |
| 2022/11/29 | 1,941 | 1,951 | 1,922 | 1,933 | -20 | -1% | 106,300 |
| 2022/11/28 | 1,979 | 1,979 | 1,943 | 1,953 | -38 | -1.9% | 129,600 |
| 2022/11/25 | 1,986 | 1,998 | 1,981 | 1,991 | +15 | +0.8% | 87,500 |
| 2022/11/24 | 1,960 | 1,987 | 1,960 | 1,976 | +16 | +0.8% | 91,000 |
| 2022/11/22 | 1,950 | 1,979 | 1,946 | 1,960 | +16 | +0.8% | 181,600 |
| 2022/11/21 | 1,931 | 1,950 | 1,931 | 1,944 | +13 | +0.7% | 61,200 |
| 2022/11/18 | 1,940 | 1,948 | 1,923 | 1,931 | -5 | -0.3% | 103,600 |
| 2022/11/17 | 1,920 | 1,937 | 1,909 | 1,936 | +16 | +0.8% | 107,500 |
| 2022/11/16 | 1,913 | 1,928 | 1,907 | 1,920 | -2 | -0.1% | 98,500 |
| 2022/11/15 | 1,910 | 1,931 | 1,907 | 1,922 | +14 | +0.7% | 87,100 |
| 2022/11/14 | 1,892 | 1,915 | 1,879 | 1,908 | +13 | +0.7% | 71,700 |
| 2022/11/11 | 1,902 | 1,906 | 1,886 | 1,895 | +36 | +1.9% | 121,400 |
| 2022/11/10 | 1,864 | 1,877 | 1,853 | 1,859 | -23 | -1.2% | 93,200 |
| 2022/11/09 | 1,884 | 1,889 | 1,869 | 1,882 | +14 | +0.7% | 58,500 |
| 2022/11/08 | 1,858 | 1,870 | 1,849 | 1,868 | +10 | +0.5% | 67,500 |
| 2022/11/07 | 1,850 | 1,858 | 1,838 | 1,858 | +22 | +1.2% | 58,800 |
| 2022/11/04 | 1,836 | 1,852 | 1,826 | 1,836 | -22 | -1.2% | 147,000 |
| 2022/11/02 | 1,815 | 1,864 | 1,815 | 1,858 | +37 | +2% | 217,400 |
| 2022/11/01 | 1,840 | 1,840 | 1,805 | 1,821 | -17 | -0.9% | 63,600 |
| 2022/10/31 | 1,804 | 1,839 | 1,804 | 1,838 | +34 | +1.9% | 136,200 |
| 2022/10/28 | 1,781 | 1,822 | 1,752 | 1,804 | -44 | -2.4% | 359,100 |
| 2022/10/27 | 1,834 | 1,853 | 1,825 | 1,848 | +8 | +0.4% | 95,000 |
| 2022/10/26 | 1,832 | 1,854 | 1,831 | 1,840 | +8 | +0.4% | 94,500 |
| 2022/10/25 | 1,821 | 1,835 | 1,813 | 1,832 | +40 | +2.2% | 96,200 |
| 2022/10/24 | 1,834 | 1,834 | 1,792 | 1,792 | -20 | -1.1% | 84,700 |
| 2022/10/21 | 1,805 | 1,823 | 1,802 | 1,812 | +6 | +0.3% | 55,600 |
| 2022/10/20 | 1,811 | 1,817 | 1,803 | 1,806 | -26 | -1.4% | 49,700 |
451～
500
件表示中 / 6825件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 234,100円 | +7.6% | +57.5% | 2.26% | 18.09倍 | 1.78倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| ネクセラファーマ | 121,500円 | +197.7% | - | 0.00% | 49.65倍 | 1.58倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 杏林製薬 | 151,800円 | +3.2% | +4.5% | 3.43% | 17.44倍 | 0.67倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 66,100円 | -3.7% | -36.7% | 3.03% | 22.42倍 | 1.47倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| サンバイオ | 101,200円 | - | - | 0.00% | - | 50.96倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
